Humira Patent Expiration What are the Consequences on AbbVie Stock

>> YOUR LINK HERE: ___ http://youtube.com/watch?v=8YOIT0SDLc4

AbbVie is one of the largest pharmaceutical companies in the world, and their flagship product, Humira, is one of the most popular and well-known medications on the market. However, Humira is facing a dangerous patent expiration in the next few years - what are the consequences on AbbVie stock? • In this video, we'll explore the potential implications of the Humira patent expiry on AbbVie's stock. We'll look at the potential sales figures, the impact on the company's profitability, and the potential effects on the stock price. So whether you're a shareholder or not, make sure to watch this video to find out all you need to know about Humira's patent expiration! • #abbvie #abbv #pharmastock • ➤ TIMESTAMPS • 00:00-00:37 Introduction • 00:37-01:39 What is AbbVie best selling drug? • 01:39-02:05 AbbVie company • 02:05-07:15 Is AbbVie a good stock to buy? • 07:15-09:59 Whats wrong with AbbVie stock? • 09:59-10:57 AbbVie stock conclusion • ➤ DISCLAIMER • We are NOT financial advisors, and nothing we say is a recommendation to buy or sell any financial instrument. We share our opinions for entertainment and educational purposes only. • We will NEVER ask you to send us money to invest for you. • Please report any suspicious emails or fake social media profiles claiming to be us. • Remember that there are no guarantees or certainties in investing. You should always do your due diligence before taking action. • Follow us on Social Media: • Twitter: / takeitfinance • Reddit: / takeitfinance

#############################

New on site